TransMedics (TMDX) Net Cash Flow (2018 - 2026)

TransMedics' Net Cash Flow history runs 9 years deep, the most recent figure standing at -$8.4 million for Q1 2026.

• In Q1 2026, Net Cash Flow rose 68.87% year-over-year to -$8.4 million; the TTM figure through Mar 2026 stood at $168.9 million (up 521.65% YoY), while the FY2025 annual figure was $150.4 million, up 361.07% from the prior year.
• Net Cash Flow was -$8.4 million for Q1 2026 at TransMedics, down from $22.1 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $386.8 million in Q2 2023 to a low of -$155.2 million in Q3 2023.
• Historically, Net Cash Flow has averaged $26.7 million across 5 years, with a median of -$3.7 million in 2022.
• The sharpest annual moves came in 2022 and 2023: Net Cash Flow surged 6821.28% in 2022, then tumbled 772.79% in 2023.
• A 5-year view of Net Cash Flow shows it stood at -$3.7 million in 2022, then sank by 772.79% to -$32.6 million in 2023, then jumped by 122.22% to $7.2 million in 2024, then jumped by 205.09% to $22.1 million in 2025, then sank by 137.84% to -$8.4 million in 2026.
• The last three Net Cash Flow figures came in at -$8.4 million (Q1 2026), $22.1 million (Q4 2025), and $65.6 million (Q3 2025), per Business Quant data.